摘要
Abstract
Objective:To explore the clinical significance of B type natriuretic peptide test in the diagnosis of acute myocardial infarction.Methods:80 patients with AMI were selected.They were divided into groups according to different treatment,20 patients with percutaneous coronary intervention(PCI) treatment were as A group,60 patients with drug thrombolysis treatment were as B group.80 patients without AMI were as the control group at the same time.After the onset of 6 to 24 hours,the blood CK-MB and TnT of patients with AMI were tested,the BNP concentration was measured by using immune fluorescence assay bedside monitor, the BNP concentration was again measured after treatment.The BNP concentration was measured in the control group.Results:The BNP level of AMI group was (593.2±159.7)pg/mL,the BNP level of the control group was (51.1±24.1)pg/mL,the difference between the two groups was statistically significant(P<0.05).Before PCI treatment and drug thrombolysis treatment,the BNP levels were compared with no statistical significance(P>0.05).After treatment,the BNP levels were compared with statistical significance(P<0.05).AMI group had 21 cases of cardiovascular events,the BNP level was (589.3±266.9)pg/mL,and 59 cases of no cardiovascular events,the BNP level was (348.5±152.6)pg/mL,the BNP levels were compared with statistical significance(P<0.05).Conclusion:One of the important indexes in the diagnosis of acute myocardial infarction is B type natriuretic peptide.The infarction severity is positively correlated with its level,the level is higher,the prognosis is worse.关键词
急性心肌梗死/B型尿钠肽/临床意义Key words
Acute myocardial infarction/B type natriuretic peptide/Clinical significance
